@article{UBHD-68255690,
  author={Richeldi, Luca and Kreuter, Michael and Quaresma, Manuel},
  title={Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib},
  subtitle={results from the TOMORROW trial and its open-label extension},
  year={2018},
  pages={581-583},
  language={eng},
  issn={1468-3296},
  volume={73},
  number={6},
  note={Published Online First 9 October 2017 ; Gesehen am 29.05.2018},
  journal={Thorax},
  doi={10.1136/thoraxjnl-2016-209701},
}
@article{UBHD-68556829,
  author={Vancheri, Carlo and Kreuter, Michael and Richeldi, Luca and Ryerson, Christopher J. and Valeyre, Dominique and Grutters, Jan C. and Wiebe, Sabrina and Stansen, Wibke and Quaresma, Manuel and Stowasser, Susanne and Wuyts, Wim A.},
  title={Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis},
  subtitle={results of the INJOURNEY Trial},
  year={2018},
  pages={356-363},
  language={eng},
  issn={1535-4970},
  volume={197},
  number={3},
  note={Published online: September 8, 2017 ; Gesehen am 24.03.2020 ; Published online: September 8, 2017},
  journal={American journal of respiratory and critical care medicine},
  doi={10.1164/rccm.201706-1301OC},
}
@article{UBHD-68556432,
  author={Vancheri, Carlo and Kreuter, Michael and Richeldi, Luca and Quaresma, Manuel and Stowasser, Susanne and Wuyts, Wim A.},
  title={Reply to Rajchgot et al., Combination Nintedanib and Pirfenidone for treatment of idiopathic pulmonary fibrosis},
  year={2018},
  pages={1105-1106},
  language={eng},
  issn={1535-4970},
  volume={198},
  number={8},
  note={Gesehen am 23.03.2020},
  journal={American journal of respiratory and critical care medicine},
  doi={10.1164/rccm.201806-1116LE},
}